The Advances In Cancer Biology - Metastasis is a research journal published by the Elsevier Inc.. The P-ISSN of this journal is .
Also, please check the following important details about advances in cancer biology - metastasis: Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate.
According to Clarivate's JCR, journals indexed in SCIE/SSCI have an impact factor.
Journal Title: | Advances in Cancer Biology - Metastasis |
Publisher: | Elsevier Inc. |
P-ISSN: | |
Open Access: | |
Status: | Active |
Scopus Coverage: | 2021-ongoing |
The advances in cancer biology - metastasis is indexed in:
An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.
The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).
According to journal website, the publication fee of advances in cancer biology - metastasis is around 2800 USD.
The advances in cancer biology - metastasis has also Journal waiver policy (for developing countries, authors etc).
An article processing charge (APC), also known as a publication fee, is a fee which is sometimes charged to authors. Most commonly, it is involved in making a work available as open access (OA), in either a full OA journal or in a hybrid journal.
The Journal Publication Time means the average number of weeks between article submission and publication. According to the journal website, the advances in cancer biology - metastasis publishes research articles in 10 weeks on an average.
Visit to the official website of the journal/ conference to check the details about call for papers.
If your research is related to the scope of the journal, then visit the official website of advances in cancer biology - metastasis and send your manuscript.